Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
ARCK Arbor Rapha Capital Bioholdings Corp I
11.9000.0000.00%
Close
01/23 16:00 ET
High
0.000
Open
0.000
Turnover
0.00
Low
0.000
Pre Close
11.900
Volume
0.00
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Arbor Rapha Capital Bioholdings Corp. I - Arbor Rapha Capital Bioholdings Corp. I Announces Nasdaq Delisting
Arbor Rapha Capital Bioholdings Corp. I - Arbor Rapha Capital Bioholdings Corp. I Announces Nasdaq Delisting
Arbor Rapha Capital Bioholdings Corp. I (NASDAQ:ARCK) Short Interest Update
Arbor Rapha Capital Bioholdings Corp. I (NASDAQ:ARCK – Get Rating) was the target of a significant increase in short interest during the month of December. As of December 30th, there was short intere
Arbor Rapha Capital Bioholdings Corp. I (NASDAQ:ARCK) Short Interest Up 1,371.4% in December
Arbor Rapha Capital Bioholdings Corp. I (NASDAQ:ARCK – Get Rating) was the target of a significant growth in short interest in December. As of December 30th, there was short interest totalling 10,300
Nasdaq Halts Arbor Rapha Capital Bioholdings Corp. I
APPH, SLRX and ARBK Among Mid-day Movers
Arbor Rapha Capital Bioholdings Corp I Trading Halted, Volatility Trading Pause
Institutional Investors Control 81% of Arbor Rapha Capital Bioholdings Corp. I (NASDAQ:ARCK) and Were Rewarded Last Week After Stock Increased 31%
A look at the shareholders of Arbor Rapha Capital Bioholdings Corp. I (NASDAQ:ARCK) can tell us which group is most powerful. With 81% stake, institutions possess the maximum shares in the company.
RSLS, ATNF and CELC Among Mid-day Movers
CACC and PMTS Among Financial Movers
Why Geron Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Gainers Vyant Bio, Inc. (NASDAQ:VYNT) shares rose 110.4% to $1.62 in pre-market trading after the company said it has engaged LifeSci Capital as its advisor to explore strategic alternatives.Humanigen
